A Cautious Yes | GenomeWeb

A Cautious Yes

A new survey suggests that many Americans would consider taking part in a clinical trial, but that most of their doctors do not discuss medical research with them, writes Ed Silverman at Pharmalot.

Silverman notes that previously cited reasons for low participation rates in trials include wide access to medication and difficulties in finding participants who are not taking other medications that could influence the trial.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.